Prostate Cancer Trial, Recruiting NCT05539677 Sponsor: N.N. Petrov National Medical Research Center of Oncology Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05539677
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed an informed consent form agreeing to take part
  • People whose tumour has been confirmed by laboratory testing of a tissue sample
  • People who are currently receiving a treatment that works throughout the body (such as chemotherapy or similar) for their cancer
  • People who have stored tumour tissue samples from a previous biopsy or surgery available
  • People who are able to provide biological samples — either a sample containing living tumour tissue or a blood sample — for immune system testing

Who may not be able to join:

  • People who have a cancer affecting the blood or lymph system (such as lymphoma or leukaemia) at the same time as their solid tumour
  • People who have previously had a stem cell or bone marrow transplant
  • People whose records of previous cancer history or general medical history are incomplete
  • People who have a known condition that affects how their immune system works from birth or early life
  • People who are taking medicines that suppress the immune system for another illness they have
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Irina Baldueva, MD, PhD, DSc, N.N. Petrov NMRC of Oncology

Phone: +78124399505

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
N.N. Petrov National Medical Research Center of Oncology
Registry
ClinicalTrials.gov
Start date
1 September 1998
Est. completion
1 December 2030

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Progression in 3 mo

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov